After-hours buzz: Facebook, Pfizer, Lexmark & more

Check out which companies are making headlines after the bell Thursday:

Facebook - The social-networking giant's Instagram announced plans to start using ads in their feed in the next couple of months. Facebook acquired the photo-sharing company last April for $1 billion. Shares of Facebook gained in extended-hours trading.

(Read More: Stocks end lower after Capitol shooting incident, shutdown woes; Dow breaks below 15000)

Pfizer - The FDA approved the pharmaceutical company's menopause drug Duavee, designed to reduce hot flashes with fewer side effects than the existing hormone-replacement therapies. Shares were flat in extended-hours trading.

Lexmark - The laser printer manufacturer acquired healthcare technology solutions company PACSGEAR in a deal worth nearly $54 million. Shares were largely unchanged in extended-hours trading.

Lannett - The generic drugmaker announced a common stock offering of indeterminate amount through Roth and Canaccord. Shares tumbled in extended-hours trading.

—By CNBC's JeeYeon Park (Follow JeeYeon on Twitter: @JeeYeonParkCNBC)

Questions? Comments? Email us at marketinsider@cnbc.com

  • Patti Domm

    Patti Domm is CNBC Executive Editor, News, responsible for news coverage of the markets and economy.

  • A CNBC reporter since 1990, Bob Pisani covers Wall Street from the floor of the New York Stock Exchange.

  • CNBC's Senior Personal Finance Correspondent

  • JeeYeon Park is a writer for CNBC.com. Follow her on Twitter: @JeeYeonParkCNBC

  • Rick Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.

  • Senior Producer at CNBC's Breaking News Desk.